UnitedHealthCare says musculoskeletal disorders (MSDs) are a top cost driver. They’re right, but insurance models aren’t designed to fix the problem.  

Back pain, joint disorders, repetitive strain injuries, and postural issues quietly account for a disproportionate share of claims, lost productivity, and downstream medical utilization. Employers feel it every renewal cycle. 

But acknowledging the problem is not the same as solving it—and this is where the traditional insurance model breaks down. 

BUCAH carriers (Blue Cross, UnitedHealthcare, Cigna, Aetna, Humana) operate within a system where rising medical costs are not just anticipated—they’re structurally embedded. Premiums are priced on projected spend plus margin. When overall utilization increases, so does revenue. In that environment, insurers are rewarded for managing musculoskeletal (MSK) costs, not meaningfully reducing them. 

That incentive gap matters. 

True MSD cost reduction doesn’t wait for pain to turn into a claim. It isn’t just rehab. It isn’t just prevention.  

It’s a functional-first performance system—built to eliminate the hurt, harm, and hidden costs of MSDs. This means care at every step: from early detection to treatment for chronic conditions. It means care that is provided when and where employees need it.  

Yet many employer plans still place friction at exactly those points—prior authorizations, visit caps, narrow networks, and confusing benefit designs that delay care until conditions worsen. 

The result? Employees cycle through imaging, prescriptions, specialist visits, and procedures that are far more expensive than early conservative care would have been. From a claims perspective, that spend is “managed.” From a human and employer perspective, it’s avoidable. 

Insurer reporting on MSD spend often reinforces this reactive posture. Claims data highlights where dollars are going, but rarely questions why care arrives so late in the injury lifecycle—or how benefit design contributes to that delay. The narrative becomes: MSK care is expensive. What’s missing is a serious examination of how insurance barriers themselves inflate long-term cost. 

If carriers were truly incentivized to fix MSDs, we’d see broader coverage for physical therapy, fewer administrative hurdles, and greater alignment with comprehensive MSK models that reward outcomes instead of volume.  

MSDs are a cost driver. Employers already know that. The more uncomfortable truth is that traditional insurance models are not designed to eliminate that cost. 

Solveglobal exists to turn any functional loss from MSDs into a business gain by delivering:  

  • Better movement 
  • 10 x engagement 
  • 30-40% net annual direct savings 

Our team promises fewer claims, lower costs, and higher trust. Our solution works because we are designed to fix your MSD problem. We break down barriers that major insurers build.  

Solveglobal protects your workforce and your bottom line. See how at solveglobal.com.